CASI (CASI Pharmaceuticals, Inc. Ordinary Shares) Stock Analysis - Hedge Fund Holdings

CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) is a publicly traded Healthcare sector company. As of May 21, 2026, CASI trades at $0.21 with a market cap of $4.26M and a P/E ratio of -0.78. CASI moved -38.97% today. Year to date, CASI is -89.88%; over the trailing twelve months it is -91.09%. Its 52-week range spans $0.21 to $7.50. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces CASI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CASI stock?

Hedge funds tracked by Rallies that own CASI include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CASI Pharmaceuticals, Inc. Ordinary Shares.

CASI Key Metrics

Key financial metrics for CASI
MetricValue
Price$0.21
Market Cap$4.26M
P/E Ratio-0.78
EPS$-0.27
Dividend Yield0.00%
52-Week High$7.50
52-Week Low$0.21
Volume9.96M
Avg Volume0
Revenue (TTM)$30.17M
Net Income$-35.84M
Gross Margin58.38%

Top Hedge Funds Holding CASI

  • Renaissance Technologies holds 39.40K shares of CASI, changed -5.06% as of Dec 31, 2024.
  • Citadel Advisors holds 22.71K shares of CASI, changed +75.86% as of Sep 30, 2024.

Latest CASI News

Recent CASI Insider Trades

  • Huang James bought 33.30K (~$142.63K) on Sep 8, 2022.
  • Huang James bought 3.11K (~$12.43K) on Sep 7, 2022.
  • Huang James bought 19.16K (~$74.60K) on Sep 6, 2022.

CASI Analyst Consensus

6 analysts cover CASI: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.

Common questions about CASI

Who owns CASI stock?
Hedge funds tracked by Rallies that own CASI include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CASI Pharmaceuticals, Inc. Ordinary Shares.
Does Rallies show 13F holders for CASI?
Yes. Rallies tracks hedge fund and 13F ownership data for CASI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CASI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CASI. It does not provide personalized investment advice.
CASI

CASI